Associations Between BMI, Serum Hormone Levels, Time Since Ovarian Insufficiency Onset, Serologic Autoimmunity, and Prevalence of Common Parameters: A cross-sectional Retrospective Study of Premature Ovarian Insufficiency

Kitirat  Techatraisak; Prasong  Tanmahasamut; Suchada  Indhavivadhana; Thanyarat  Wongwananuruk; Manee  Rattanachaiyanont; Chongdee  Dangrat

Authors

Kitirat Techatraisak Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Prasong Tanmahasamut Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Suchada Indhavivadhana Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Thanyarat Wongwananuruk Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Manee Rattanachaiyanont Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Chongdee Dangrat Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

Keywords:

premature ovarian insufficiency, body mass index, years since premature ovarian insufficiency, follicular stimulating hormone, estradiol, serologic autoimmunologic parameters

Abstract

OBJECTIVE Premature ovarian insufficiency (POI) affects 1:100 women before the age of 40. The objectives include exploring correlations between body mass index, years since the onset of premature ovarian insufficiency, follicular stimulating hormone, and estradiol; and studying prevalence of five common serologic autoimmunologic para-meters during POI diagnosis.

METHODS The records of idiopathic POI patients presenting with secondary amenorrhea who visited the Gynecologic Endocrinology Unit, Siriraj Hospital, between January 1, 2000 and December 31, 2016 were reviewed. Extracted data included body mass index, years since premature ovarian insufficiency onset, levels of follicular stimulating hormone and estradiol. Five common serologic autoimmunologic para-meters were also retrieved where available.

RESULTS Among the 161 idiopathic POI patients analyzed, a significant reverse correlation was found between serum follicular stimulating hormone and estradiol (r=-0.209, p=0.008), while no correlations were identified between body mass index, years since the onset of premature ovarian insufficiency, and serum estradiol (p=0.141, p=0.240, respectively). After excluding cases with abnormal karyotypes which can potentially cause POI, the remaining 146 cases was comprised of 72 cases with a normal 46,XX karyotype (the first group) and 74 cases who declined karyotype investigation (the second group). At least one of the serologic autoimmunologic parameters was investigated in 43 cases in the first group and in 20 cases in the second group. Anti-nuclear antibody was the most prevalent in the first group (25.0%) while anti-thyroglobulin was the most prevalent in the second group (30.7%).

CONCLUSIONS Only serum follicular stimulating hormone and estradiol exhibited significant reverse correlation in POI cases with secondary amenorrhea. Baseline serologic autoimmunologic parameters were positive but didn’t indicate autoimmune diseases during POI diagnosis.

References

Goswami D, Conway GS. Premature ovarian failure. Horm Res. 2007;68:196-202.

Sullivan SD, Sarrei PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016;106:1588-99.

Gupta A, Tiwari P. Khare C. Premature ovarian insufficiency: A review. EMJ Repro Health. 2019. doi: 10.33590/emjreprohealth/19-0041

Dormniz N, Meirow D. Premature ovarian insufficiency and auto immune diseases. Best Pr Res Clin Obstet Gynecol. 2019;60:42-55.

Luborsky J, Meyer P, Sowers M, Gold E, Santoro N. Premature menopause in a multiethnic population study of the menopause transition. Hum Reprod. 2003;18:199-206.

Meldrum DR, Davidson BJ, Tataryn IV, Judd HL. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol. 1981;57:624-8.

Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003;86:3-5.

Purohit A, Reed MJ. Regulations of estrogen synthesis in postmenopausal women. Fertil Steril. 2002;67:979-83.

Laven JSE. Primary ovarian insufficiency. Semin Reprod Med. 2016;34:230-4.

Jiao X, Khang H, Ke H, Zhang J, Cheng L, Liu Y, et al. Premature ovarian insufficiency: Phenotypic characterization within different etiologies. J Clin Encocrinol Metab. 2017;102:2281-90.

Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, Grymowica M, Smolarczyk K, Kostrzaj A, et al. Autoimmune diseases in patients with premature ovarian insufficiency - Our current state of knowledge. Int J Mol Sci. 2021;22:2594.

Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HA. Characterization of idiopathic premature ovarian failure. Fertil Steril. 1996;65:337-41.

Kirshenbaum M, Orvieto R. Premature ovarian insufficiency (POI) and autoimmunity - an update appraisal. J Assist Reprod Genet. 2019;36:2207-15.

Dragojevic-Dikic S, Marisavljevic D, Mitrovic A, Dikic S, Jovanovic T, Jankovic-Raznatovic S. An immunologic insight into premature ovarian failure (POF). Autoimmune Rev. 2010;11:771-4.

Sharif K, Watad A, Bridgewood C, Kandac D, Amital H, Shoenfeld Y. Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pr Res Clin Endocrinol Metab. 2019;33:101323.

Zhen X, Qiao J, Li R, Wang L, Liu P. Serologic autoimmunologic parameters in women with primary ovarian insufficiency. BMC Immunology. 2014;15:1-6.

Techatraisak K, Wattayanon K. The correlation between serum estradiol level and body mass index in postmenopausal women: A cross-sectional study at the menopause clinic, Siriraj Hospital. Thai J Obstet Gynaecol. 2017;25:111-8.

Randolph JF, Sowers MF, Bondarenko IV, Karlow SD, Luborsky JL, Little RJ. Change in estradiol and follicular-stimulating hormone across the early menopause transition: Effects of ethnicity and age. J Clin Endocrinol Metab. 2004;89:1555-61.

Freeman E, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause. 2010;17:718-26.

Chompootweep S, Tankeyoon M, Yamarat M, Poomsuwan P, Dusitsin N. The menopausal age and cli-macteric complaints in Thai women in Bangkok. Maturitas. 1993;17:63-71.

Rennevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the postmenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 1995;21:103-30.

WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-63.

Burger HG, Dudly EC, Hopper JL, Groome N, Gulthrie JR, Green A, et al. Prospective measured levels of serum follicular stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab. 1999;84:4025-30.

Pouresmaeili F, Fallahian M & Abdollahi DZ. X chromosome deletion in an Iranian women with premature ovarian failure and a minireview. Urology & Nephrology Open Access J. 2017;4:00125. doi: 10.15406/unoaj.2017.04.00125.

Forges T, Monnier-Barbarino P, Faure CG, Bene CM. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update. 2004;10:163-75.

Panay N, Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynecol. 2009;23:129-40.

Pires ES, Parte PP, Mekerji PK, Khan SA, Khole N. Naturally occurring anti-albumin antibodies are responsible for false positive in diagnosis of autoimmune premature ovarian failure. J Histochem Cytochem. 2006;54:397-405.

Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EN, Spencer CA, et al. Serum TSH, T4 and thyroid antibodies in the United States population (1988 to 1994). National Health and Nutritional Examination Survey (NHANES III) J Clin Endocrinol Metab. 2002;87:489-99.

Goswami R, Marwaha RK, Goswami D, Gupta N, Ray D, Tomar N, et al. Prevalence of thyroid antoimmunity in sporadic idiopathic hypoparathroidism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab. 2006;91:4256-9.

Webber L, Davies M, Anderson R, Bartlett J, Bratt D. Cartwright B. et al. ESHRE guideline: management in women with premature ovarian insufficiency. Hum Reprod. 2016;31:926-37.